Informa Connect Medical Brands
My Account
Sign In
Register
Subscribe
Cart
Cart

Derm Appeal Blog

A dose of news brought to you by LiVDerm.

LiVDerm Revolutionizing Dermatology
Latest Blogs
Aesthetic Dermatology
Advancing the Industry: How PAs Are Shaping the Future of Dermatology and Aesthetics 
Advancing the Industry: How PAs Are Shaping the Future of Dermatology and Aesthetics 
October 8, 2025
This PA Week 2025, we celebrate the remarkable role and lasting impact of our nation’s Physician Assistants (PAs) — the...
Read More
Managing Pediatric Atopic Dermatitis: Balancing Fundamentals and Emerging Therapies
October 2, 2025
Atopic Dermatitis (AD) remains the most prevalent dermatologic condition in infants and children, affecting an estimated 10-20% worldwide. For clinicians,...
Ruxolitinib Cream for Pediatric Atopic Dermatitis: What Clinicians Need to Know 
September 25, 2025
The U.S. Food and Drug Administration (FDA) recently expanded the indication for ruxolitinib cream (Opzelura®) to include children aged 2–11...
B-VEC FDA Label Expansion for DEB: What It Means for Patients and Clinicians 
September 17, 2025
In May 2023, the FDA approved beremagene geperpavec (B-VEC, Vyjuvek®), the first topical gene therapy for dystrophic epidermolysis bullosa (DEB)....
Explore Blogs
Filter by Category
Filter by Category
Live Events

South Beach Symposium 2026

February 5-7, 2026
Miami Beach, FL
Register Now
Latest Articles

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.

QUICK LINKS
Professional Education
Industry Resources

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.